Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

“Someone has to be first” – Kiilto offers game-changing, green adhesive innovations for the packaging industry

Kiilto is a chemical industry pioneer that has its gaze firmly fixed on the future – on a sustainable future, to be exact. The road to a greener tomorrow is paved with new innovations, such as the world's first biodegradable hot melt adhesive.Kiilto, a 100-year-old family business offers chemical industry solutions in four business areas: Industrial Adhesives and Fireproofing, Construction, Professional Hygiene and Consumer Goods. “Among the things we are known for are our top-quality adhesive solutions. In this business area, our customer base includes companies from the packaging and

World War II drama ‘Gold Run’ is Viaplay’s first Norwegian original film

· Feature-length film stars Jon Øigarden (‘Exit’), Sven Nordin (‘Wisting’) and Axel Bøyum (‘Delete Me’) · ‘Gold Run’ is the first Viaplay Original film from Norway · Viaplay to premiere at least 60 Originals in 2022 The first-ever Norwegian Viaplay Original film will be the World War II drama ‘Gold Run’, based on the extraordinary true story of a group of unlikely resistance fighters who smuggled Norway’s gold reserves out of the country ahead of invading Nazi forces. Jon Øigarden (‘Exit’), Sven Nordin (‘Wisting’) and Axel Bøyum (‘Delete Me’) lead an all-star Norwegian cast in the

Reminder - Invitation to Pexip Q3 2021 Results Presentation

Pexip will present its third quarter results for 2021 today, 11 November, at 17:00 CET. The report and presentation will be made available at 16:30 CET at investor.pexip.com and newsweb.no.Pexip will host a physical presentation at Felix Konferansesenter (Atlantic), Bryggetorget 3, Oslo, Norway. For registration, please follow this link and select either in-person presentation in Oslo or webcast: https://www.pexip.com/q3-2021-results-presentation-registration A live webcast of the event will also be streamed via https://channel.royalcast.com/landingpage/hegnarmedia/20211111_17/

Elkem Silicones will present silicone solutions for additive manufacturing/3D printing at formnext 2021 in Frankfurt.

Elkem Silicones will be present at the upcoming Formnext show, the leading industry platform for additive manufacturing and industrial 3D printing in Frankfurt in Germany from November, 16[th] to 19[th] and will showcase its wide portfolio of silicone solutions for Additive Manufacturing/3D Printin.To answer the challenging megatrends, Elkem Silicones has created a brand-new technology, called AMSil™ & AMSil SILBIONE™ series, to make functional parts based on genuine silicone elastomers by Additive Manufacturing/3D Printing. • AMSil™ 20000 series for use in industrial applications (

BioStock studio: Saniona celebrates a decade of progress

Today marks Saniona’s 10th anniversary since its founding. BioStock was visited in the studio by the company’s founder Jørgen Drejer, now Chief Scientific Officer, who talks about the transformation that the company has undergone during this decade. We also learn more about the success of the primary drug candidate Tesomet, the importance of now having a US-based management team and his view of the company’s future.Watch the interview with Jørgen Drejer at biostock.se : https://www.biostock.se/en/2021/11/biostock-studio-saniona-celebrates-a-decade-of-progress/

BioStock: SynAct Pharma’s CSO and CMO comment on clinical development

SynAct Pharma continues to make progress in the development of the anti-inflammatory drug candidate AP1189. The company recently announced that AP1189 can be dosed for three months in future clinical studies, supported by preclinical toxicology results. Also, SynAct has now formulated AP1189 as a tablet – which is another big step for future clinical development. By the end of November, SynAct Pharma expects to present key results from BEGIN, a clinical phase IIa study in the primary indication rheumatoid arthritis. BioStock reached out to the company’s CSO Thomas Jonassen and CMO Anders Dyhr

Comment on reported PDMR transaction by BGA Invest

Minesto's largest owner, BGA Invest AB, has today reported a sale of shares in Minesto AB to the Swedish financial supervisory authority’s PDMR* transactions register. BGA Invest remains the largest owner, and an active and long-term owner, in Minesto.BGA Invest AB has reported that the company has sold 1,500,000 shares, corresponding to approximately 4.8 percent of BGA Invest's holding in Minesto. The buyer of the shares is a European financial fund. After the transaction, BGA Invest remains the largest owner in Minesto with a holding of 29,800,840 shares, which corresponds to

BioStock: Saniona’s founder on 10 years of history and the future

Today marks the 10th anniversary of biotech company Saniona being founded in Denmark. The company started with only preclinical assets and has now grown to have three programs in clinical stages of development and a U.S.-based executive team with a razor-sharp focus on developing and commercializing rare disease drugs. BioStock reached out to the company’s founder and current Chief Scientific Officer, Jørgen Drejer, to get his view of the transformation the company has undergone over the past decade and his thoughts on the future.Read the full interview with Jørgen Drejer at biostock.se:

Peab builds new swimming pool facility in Årjäng

Peab has been commissioned to build a new swimming pool facility in Årjäng. The customer is Årjäng Municipality and the contract is worth SEK 155 million.The 1,500 m2 swimming pool facility will consist of a 25 meter pool with six swimming lanes, a trampoline and a multi-pool with a height adjustable bottom. There will also be a relax area with a Jacuzzi and sauna, a children’s section with a children’s pool as well as a gym, a group exercise room and a wellness area connected to the swimming pool facility. “We’re already building homes and a preschool in the Årjäng area and are happy

2020 Bulkers Ltd. (2020) - Extended time charter agreements for Bulk Santiago and Bulk Seoul

Hamilton, Bermuda, November 11, 2021   2020 Bulkers has entered into extended 10-13 month time charter agreements for Bulk Santiago and Bulk Seoul with Koch. The extensions will commence February 1, 2022, in direct continuation of their current charters.  The vessels will earn an index-linked rate, reflecting a significant premium to the Baltic 5TC index. The time charters also include a profit sharing of any economic benefit derived from operating the vessels scrubbers, as well as certain rights to convert the time charters to fixed rates on the basis of the prevailing FFA curve

Scandinavian ChemoTech AB (publ) Interim report Q3 January – September 2021 - Executive Summary of the third quarter

Third quarter · Net sales amounted to kSEK 9 (41)  · Profit before tax amounted to kSEK -5 732 (-2 851) · Earnings per share amounted to SEK -0,65 (-0,47) · Cash flow from operating activities totaled to kSEK -7 014 (-2 836) Period 1 January - 30 September · Net sales amounted to kSEK 39 (131) · Profit before tax amounted to kSEK -12 313 (-8 872) · Earnings per share amounted to SEK -1,48 (-1,95) · Cash flow from operating activities totaled to kSEK -13 428 (-8 701) · The order book amounted to kSEK 1 100 (527) at the end of the period Important events

Contract award for CSVs

Solstad Offshore ASA is pleased to announce award of two term contracts for it`s medium size construction vessels. Fugro Netherlands Marine BV has chartered the CSV “Normand Mermaid” for a period of 16 months firm. The contract will commence December 2021. The present Client on CSV “Normand Baltic” has exercised their option to extend the contract with another 8 months to July 2022 with further 90 days options thereafter. The vessel is operating in Taiwan where she is supporting offshore-wind projects. Skudeneshavn November 11[th], 2021 ContactsLars Peder Solstad CEO, at +47

Interim Financial Report January – September 2021

Solid demand and good performanceMarket recovery has continued during the first nine months of 2021. However, supply chain challenges have impacted our Q3 sales. Demand for LEAX products and services remained strong across all our end markets. During quarter three we had to reduce production volumes due to short notice stoppages at key customer production locations. This led to slightly lower sales primarily in the Commercial Vehicle segment with Q3 revenue coming in at SEK 365.0 million (298.4). Our revenue still represented an increase over Q3 2020 of 22.3% and reflects the underlying

Viking Supply Ships AB (publ) Interim Report Q3 2021

Press release  11 November 2021Despite that the overall activity within the offshore oil and gas industry is still subdued, the market conditions for OSVs in the North Sea saw a modest increase during the third quarter. Revenue for the third quarter was MSEK 79 (100), EBITDA was MSEK 0 (2), and the net result was MSEK -18 (-14). Year-to-date revenue was MSEK 226 (230), EBITDA was MSEK -38 (-69), and the net result was MSEK -91 (-146). During the quarter the Group decided on a rights issue, which was successfully completed shortly after the quarter, raising MSEK 98 in net proceeds.

Cantargia publishes interim report for third quarter 2021

Cantargia AB’s (”Cantargia”) interim report for the period January until September 2021 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports. Significant events in the third quarter · New positive interim data on treatment of patients with non-small cell lung cancer (NSCLC) in the CANFOUR study were presented at the ESMO conference; next steps were initiated for expansion of the clinical development of nadunolimab and platinum-based chemotherapy in non-squamous NSCLC. · The CIRIFOUR study was fully recruited; next steps were also initiated

INTERIM REPORT JANUARY - SEPTEMBER 2021

JULY–SEPTEMBER 2021 · Net sales amounted to MSEK 293.9 (247.0). · Growth was 19% (5). · EBIT amounted to MSEK 48.5 (37.5). · EBIT margin amounted to 16.5% (15.2). · Net income was MSEK 39.4 (28.3). · Earnings per share1 amounted to SEK 0.79 (0.57). CEO PATRIK ANDERSSON:STRONG GROWTH WITH A HIGH EBIT MARGIN AND GOOD CASH FLOWThe quarter was dominated by continued profitable growth and with a substantial increase to our order intake for the E-mobility product area. However, sales of E-mobility products were limited due to a lack of electronic components, which

Interim report January – September 2021

The period in summary Third quarter July 1 – September 30, 2021 · On August 16th the European Commission granted a Marketing Authorisation for Strangvac within the European Union. · The Veterinary Medicines Directorate (VMD) of the United Kingdom granted a Marketing Authorisation for Strangvac within the UK on September 17th. · On August 23rd the Norwegian Medicines Agency (NoMA), granted a marketing authorisation for Strangvac in Norway. Figures in brackets indicate outcome for the corresponding period of the previous financial year. The financial information presented

AirForestry: Re-inventing Forestry by harvesting trees from the air with electric drones

Balancing our need for high quality renewable biomaterial with our need for biodiversity and healthy forest ecosystems is discussed in both the UN climate summit in Glasgow and Swedish universities. AirForestry offers an answer to that dilemma, using electric drones to create the sustainable, long-term and efficient forestry of the future. Thinning, or removing small trees to make room for the remaining trees to grow bigger, makes forests more productive. Thinning from the air using electric harvesting drones doesn’t damage surrounding shrubs or trees. Drones don’t touch the ground,

New CEO in 24SevenOffice Group AB

Eirik Stranden will take over as the CEO of 24SevenOffice Group AB from Staale Risa with immediate effect. Eirik has been responsible for the business development division of 24SevenOffice for the last 6 months and is a former management consultant from Boston Consulting Group and EY. Staale Risa will continue in the Board of directors and be available to support Eirik in a transition period.  Staale Risa is suggested to be new deputy chairman of the board in the Company following his own ambitions to focus more on long-term strategies and development of new business areas rather than

Vår Energi sets new, ambitious climate goals – aims to be climate neutral by 2030

“The clock is ticking, and action is needed. Sustainability and environment now runs as a green thread through all activities in Vår Energi. We have established a roadmap for how we will achieve the main goal of close to zero greenhouse gas emissions in 2050. Becoming climate neutral by 2030 is an important step on the road to zero", says Vår Energi CEO, Torger Rød. The aim is to be climate neutral in Scope 1 and 2 activities by 2030 - which means net zero greenhouse gas emissions from all the 35 producing oil and gas fields where Vår Energi is operator or partner. In addition, emissions

Odfjell SE: Potential buyback of own bonds and tap issue

Odfjell SE (the "Company") has mandated Nordea and Swedbank to explore the possibility of a conditional buyback of the outstanding bonds maturing in June 2022 ISIN NO0010796238 (ODF09) and a potential tap issue of the outstanding bond maturing in September 2023 ISIN NO 0010832181, subject to market conditions. The purpose of the contemplated transactions is to part refinance ODF09 in accordance with the Company’s finance strategy. For questions, please contact: Terje Iversen, CFO:Tel: +47 932 40 359E-mail: terje.iversen@odfjell.com  Gustav Sannem, VP Finance: Tel: +47 452

Interim report July – September 2021

Third quarter in brief · Net sales amounted to 13.6 million SEK (10.5), which means a sales growth of 29 percent. · Operating profit amounted to 2.2 million SEK (-0.06). · Net profit for the period amounted to 2.3 million SEK (-0.15). · Earnings per share amounted to 0.06 SEK (-0.01). First nine months in brief · Net sales for the first nine months amounted to 40.1 million SEK (32.9), which means a sales growth of 22 percent. ·Operating profit amounted to 4.8 million SEK (-2.2). ·Profit for the period amounted to 4.8 million SEK (-2.3). ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top